Authors
Latest:
A Team Approach to Asleep Deep Brain StimulationHenry Ford Health System’s investment in advanced DBS technology and its commitment to multidisciplinary care has helped them become a leading treatment center for Parkinson disease and related movement disorders.
Latest:
Assessing the Impact of Gut Microbiota on Neuroprotection in Alzheimer Disease: Yannick J. Wadop Ngouongo, PhDThe postdoctoral researcher at The University of Texas Health Science Center at San Antonio talked the gut microbiome and neurological disorders, focusing on the potential role of gut microbiota imbalance in the pathogenesis of conditions like Alzheimer disease. [WATCH TIME: 5 minutes]
Latest:
AUPN Leadership Minute Episode 38: Visa Issues for FacultyEpisode 38 of the AUPN Leadership Minute features Muhammad "Mud" Alvi, MD, of West Virginia University Robert C. Byrd Health; and David B. Watson, MD, of West Virginia University Robert C. Byrd Health. [WATCH TIME: 5 minutes]
Latest:
Effects of Long-term CPAP Therapy in Multiple Sclerosis: Daria Trojan, MD, MScThe associate professor in the department of neurology and neurosurgery at McGill University discussed results from a study on the long-term use of continuous positive airway pressure treatment among patients with multiple sclerosis and sleep apnea presented at MSMilan 2023. [WATCH TIME: 5 minutes]
Latest:
Promising Disease-Modifying Therapies in Parkinson DiseaseDespite years of use of gold-standard therapy levodopa, therapeutic development in Parkinson disease has advanced rapidly and expanded to numerous novel pathways and targets.
Latest:
Key Considerations in Treatment of Spinal Muscular Atrophy / Considerações essenciais para o tratamento da atrofia muscular espinhalThe expert panel shares clinical pearls for treatment and management of Spinal Muscular Atrophy. O painel de especialistas compartilha recomendações valiosas para o tratamento e manejo da atrofia muscular espinhal.
Latest:
Aducanumab’s Implications for Future Clinical Trials: Pierre N. Tariot, MDIn addition to his work study pimavanserin in treating dementia-related psychosis, the director of the Banner Alzheimer’s Institute commented on the potential for aducanumab in Alzheimer disease.
Latest:
Challenges With Addressing Neurodegeneration in Poststroke Patients: Stephen FromThe chief executive officer of Aruna Bio discussed the reasons for the failure of neuroprotective agents in ischemic stroke trials and why AB126 has potential to restore neurodegeneration in such affected patients. [WATCH TIME: 3 minutes]
Latest:
Role of Cholinergic Transcripts in Sex-Specific Declines of Alzheimer Disease: Hermona Seroq, PhDThe professor of molecular neuroscience at the Edmond and Lily Safra Center for Brain Sciences discussed the premise behind a study of RNA-sequencing data to better understand the reasons why females suffer accelerated dementia. [WATCH TIME: 9 minutes]
Latest:
Trends in Movement Disorder Research: Ihtsham ul Haq, MD, FAANThe chief of Movement Disorders Division at the University of Miami Miller School of Medicine discussed some of the recent focused efforts to uncover more about Parkinson disease and what is on the horizon.
Latest:
Jonathan Graff-Radford, MD: Blood Tests as a Diagnostic Innovation in Alzheimer DiseaseThe neurologist at Mayo Clinic detailed promising diagnostic tools, including the revelation of blood tests in patients with Alzheimer disease.
Latest:
CNS Demyelination and Autoimmune Neurology: Spencer Hutto, MDThe fellow of autoimmune neurology at Massachusetts General Hospital also discussed concerns of associations between multiple sclerosis and COVID-19.
Latest:
Elias Kouchakji, MD: Investigating Pamrevlumab for DMD in Phase 3 LELANTOS StudyThe senior vice president of clinical development, drug safety, and pharmacovigilance at FibroGen provides details of the phase 3 LELANTOS trial of pamrevlumab in Duchenne muscular dystrophy.
Latest:
Weighing Approaches on Preventive Use, Medication Overuse in Chronic Migraine: Vincent Martin, MDThe president of the National Headache Foundation discussed whether switching or continuing preventive medications has a benefit in patients who have chronic migraine with medication overuse. [WATCH TIME: 4 minutes]
Latest:
Future Research Regarding Anticoagulant Use in Reducing Recurrent Stroke: Alexander Merkler, MD, MSThe assistant professor of neurology at Weill Cornell Medicine discussed his future aspirations to uncover more about the beneficial effects of anticoagulants in reducing recurrent stroke. [WATCH TIME: 3 minutes]
Latest:
Current Roadblocks Toward Expanding Gene Therapy Across Pediatric Neurology: Shafali Jeste, MDThe chief of neurology and co-director of the Neurological Institute at the Children’s Hospital Los Angeles described some of the major resource and policy-level barriers for gene therapy in pediatric neurological conditions. [WATCH TIME: 6 minutes]
Latest:
Shaping the Future of Medical Research Using Insights From the Headache Community: Amynah Pradhan, PhDThe associate professor of psychiatry at the University of Illinois at Chicago talked about the importance of diverse insight and perspectives from the headache community in shaping medical research priorities. [WATCH TIME: 3 minutes]
Latest:
AUPN 2022 Veterans Health Administration WorkshopGlenn Graham, MD, PhD; and Sharyl Martini, MD, PhD, moderate a discussion with 4 clincial experts to advance specialized clinical care, education and research for Veterans with movement disorders, multiple sclerosis, epilepsy and seizures, and headache. [WATCH TIME: 1 hour, 52 minutes]
Latest:
Key Takeaways From a Study of FUS in Early AD Dementia: Ali Rezai, MDThe executive chair at the Rockefeller Neuroscience Institute at West Virginia University shed light on early data from a small sample of patients with early Alzheimer disease who underwent focused ultrasound treatment. [WATCH TIME: 5 minutes]
Latest:
Anecdotal Evidence and the Need for Trials of Psychedelics in Headache Disorders: Bryan Roth, MD, PhDThe Michael Hooker Distinguished Professor and director of the NIMH psychoactive drug screening program at University of North Carolina School of Medicine discussed the need for large placebo-controlled trials of psychedelics in migraine disorders. [WATCH TIME: 4 minutes]
Latest:
Use of Targeted Therapies in the Treatment Algorithm of MGExpert neurologists discuss the treatment algorithm of MG, focusing on the use of targeted therapies as well as barriers to their use.
Latest:
Next Steps for ATA188, Research Related to EBV and Multiple Sclerosis: AJ Joshi, MDThe chief medical officer at Atara Biotherapeutics provided insight on the future direction of its investigational agent ATA188 following new data that suggested a link between Epstein-Barr virus and multiple sclerosis. [WATCH TIME: 4 minutes]
Latest:
Future Research on Cannabis Use to Treat Migraine: Nathaniel Schuster, MDThe pain management specialist and headache neurologist at the University of California San Diego Center for Pain Medicine discussed the different forms of cannabis and the need to conduct larger, multicenter studies to better understand its effects in migraine. [WATCH TIME: 3 minutes]
Latest:
Lifting Barriers to Equitable Care in EpilepsyFour neurologists treating patients with epilepsy share their experience in and out of the clinic tackling issues of access for their patients.
Latest:
The Changing Landscape of Preventative Migraine TreatmentsA panel of expert neurologists shares advice for community neurologists on preventive migraine treatment and exciting therapies to look forward to.
Latest:
AUPN Leadership Minute Episode 9: Engaging Medical Students in Neurology – Part 2Episode 9 of the AUPN Leadership Minute features Donald S. Higgins, Jr., MD, of the Veterans Health Administration; and Douglas J. Gelb, MD, PhD, of the University of Michigan [WATCH TIME: 5 minutes]
Latest:
The Evolving Diagnostic Criteria for Multiple SclerosisJoin Ahmed Obeidat, MD, PhD; Hesham Abboud, MD, PhD; and Rana K. Zabad, MD, FAAN, for perspectives on how the diagnostic criteria for multiple sclerosis have evolved over time.
Latest:
Building a Greater Understanding for NMOSD Treatments, Neurodegeneration: John Chen, MD, PhDThe neuroophtalmologist at Mayo Clinic detailed improvements in prescribing methods for NMOSD treatments and the conversations surrounding reversing neurodegeneration. [WATCH TIME: 3 minutes]
Latest:
The Unresolved Bottleneck of Accessing Care for Mental Health in MS: Bernd C. Kieseier, MDThe global program head of the development unit for neuroscience at Novartis talked about the evolving landscape of mental health care for multiple sclerosis including the accessibility barrier that remains for patients in many regions. [WATCH TIME: 4 minutes]
Latest:
Promising Preclinical Evidence of Skeletal Muscle Regenerator SAT-3247: Frank GleesonThe president and chief executive officer of Satellos Bioscience provided an overview of the previously observed preclinical data supporting SAT-3247 as a potential therapy for muscular dystrophies. [WATCH TIME: 4 minutes]
